Partha Anbil

Can deeper data from specialty pharmacy providers bolster both patient outcomes and financial returns?

Strategies and recommendations for driving value in today’s AI-enhanced prescribing environment.

The window of opportunity for launch is short and unforgiving, and the success depends on flawless execution of launch activity across countries and functions.

A patient-centric approach to drug development delivers the benefits that actually create value.

Innovation in hub program design for patient scrip data and clinical support services can lead to increased market share in the hotly contested specialty medicine space.